-
25 APR 2012
/ Other
Watson to Acquire Actavis Group for EUR 4.25 Billion
Watson Pharmaceuticals, Inc. (NYSE: WPI) and Actavis Group today jointly announced that Watson has entered into a definitive agreement to acquire privately held Actavis for approximately EUR4.25
-
04 JAN 2012
/ Product
Actavis Launches Generic Equivalent of Ritalin LA® in the US, with 180-day Exclusivity.
Morristown, NJ, January 4, 2012 - Actavis Group, an international generic pharmaceuticals company, today announced that it recently received approval from the US Food & Drug Administration to
-
03 JAN 2012
/ Product
Actavis First-To-Market with Generic Equivalents of Clobex® Shampoo and Clobex® Topical Lotion
Morristown, NJ, January 3, 2012 - Actavis Group, an international pharmaceuticals company, today announced that it has begun shipping Clobetasol Propionate Shampoo and Clobetasol Propionate
-
21 DEC 2011
/ Product
Actavis to Launch Novel Pain Medication in the US
-
11 NOV 2011
/ Product
Actavis Launches Generic KADIAN® Capsules in the US
-
01 NOV 2011
/ Other
Counterfeit Phentermine Found in US
-
26 OCT 2011
/ Other
Actavis Medication Stolen While in Transit
-
05 OCT 2011
/ Other
Actavis Plans Latin America Expansion
-
15 SEP 2011
/ Product
Actavis Launches Generic Keppra XR® Tablets in the US
-
15 JUL 2011
/ Product
Actavis Launches Oxymorphone Hydrochloride Extended-Release Tablets, CII in the US